- Home
- OPRX vs KRRO Comparison
OPRX vs KRRO Comparison
Compare OPRX & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRX
- KRRO
- Stock Information
- Founded
- OPRX 2006
- KRRO 2014
- Country
- OPRX United States
- KRRO United States
- Employees
- OPRX N/A
- KRRO N/A
- Industry
- OPRX Business Services
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- OPRX Consumer Discretionary
- KRRO Health Care
- Exchange
- OPRX Nasdaq
- KRRO Nasdaq
- Market Cap
- OPRX 380.6M
- KRRO 358.3M
- IPO Year
- OPRX N/A
- KRRO 2019
- Fundamental
- Price
- OPRX $18.53
- KRRO $44.52
- Analyst Decision
- OPRX Buy
- KRRO Strong Buy
- Analyst Count
- OPRX 8
- KRRO 7
- Target Price
- OPRX $11.81
- KRRO $96.71
- AVG Volume (30 Days)
- OPRX 373.4K
- KRRO 233.8K
- Earning Date
- OPRX 11-12-2025
- KRRO 11-11-2025
- Dividend Yield
- OPRX N/A
- KRRO N/A
- EPS Growth
- OPRX N/A
- KRRO N/A
- EPS
- OPRX N/A
- KRRO N/A
- Revenue
- OPRX $104,748,000.00
- KRRO $6,281,000.00
- Revenue This Year
- OPRX $17.92
- KRRO $116.91
- Revenue Next Year
- OPRX $10.91
- KRRO N/A
- P/E Ratio
- OPRX N/A
- KRRO N/A
- Revenue Growth
- OPRX 25.89
- KRRO N/A
- 52 Week Low
- OPRX $3.78
- KRRO $10.29
- 52 Week High
- OPRX $20.70
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- OPRX 49.17
- KRRO 66.86
- Support Level
- OPRX $17.45
- KRRO $43.41
- Resistance Level
- OPRX $18.93
- KRRO $49.01
- Average True Range (ATR)
- OPRX 1.14
- KRRO 4.33
- MACD
- OPRX -0.24
- KRRO 0.25
- Stochastic Oscillator
- OPRX 21.08
- KRRO 77.85
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.